Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins - Significance for the patient

Christian Hartinger; Stephan Hann; Gunda Köllensperger; Michael Sulyok; Michael Größl; Andrei Timerbaev; Alexander V. Rudnev; Gerhard Stingeder; Bernhard Keppler

Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins - Significance for the patient

Christian Hartinger
, Stephan Hann
, Gunda Köllensperger
, Michael Sulyok
, Michael Größl
, Andrei Timerbaev
, Alexander V. Rudnev
, Gerhard Stingeder
, Bernhard Keppler

Department of Inorganic Chemistry

Publications: Contribution to journal › Article › Peer Reviewed

Original language	English
Pages (from-to)	583-585
Number of pages	3
Journal	International Journal of Clinical Pharmacology and Therapeutics
Volume	43
Issue number	12
Publication status	Published - 2005

Austrian Fields of Science 2012

104003 Inorganic chemistry
301904 Cancer research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://www.scopus.com/scopus/inward/record.url?eid=2-s2.0-29444434345&partnerID@&rel=R5.6.0

Cite this

Hartinger, C., Hann, S., Köllensperger, G., Sulyok, M., Größl, M., Timerbaev, A., Rudnev, A. V., Stingeder, G., & Keppler, B. (2005). Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins - Significance for the patient. International Journal of Clinical Pharmacology and Therapeutics, 43(12), 583-585. http://www.scopus.com/scopus/inward/record.url?eid=2-s2.0-29444434345&partnerID@&rel=R5.6.0

@article{2dea8d93732c437989eaaea7138f19bc,

title = "Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins - Significance for the patient",

author = "Christian Hartinger and Stephan Hann and Gunda K{\"o}llensperger and Michael Sulyok and Michael Gr{\"o}{\ss}l and Andrei Timerbaev and Rudnev, \{Alexander V.\} and Gerhard Stingeder and Bernhard Keppler",

note = "Coden: ICTHE Affiliations: Institute of Inorganic Chemistry - Bioinorganic, Environmental and Radiochemistry, University of Vienna, W{\"a}hringer Stra{\ss}e 42, 1090 Vienna, Austria; Department of Chemistry, BOKU, University of Natural Resources and Applied Life Sciences, Vienna, Austria; Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Moscow, Russian Federation Adressen: Keppler, B.K.; Inorganic Chemistry - Bioinorganic, Environmental and Radiochemistry; University of Vienna; W{\"a}hringer Stra{\ss}e 42 1090 Vienna, Austria; email: [email protected] Source-File: ChemieErgScopus.csv Import aus Scopus: 2-s2.0-29444434345 Importdatum: 09.01.2007 14:08:38 12.02.2008: Datenanforderung 2112 (Import Sachbearbeiter) 09.02.2010: Datenanforderung UNIVIS-DATEN-DAT.RA-2 (Import Sachbearbeiter)",

year = "2005",

language = "English",

volume = "43",

pages = "583--585",

journal = "International Journal of Clinical Pharmacology and Therapeutics",

issn = "0946-1965",

publisher = "DUSTRI-VERLAG DR KARL FEISTLE",

number = "12",

}

Hartinger, C, Hann, S, Köllensperger, G, Sulyok, M, Größl, M, Timerbaev, A, Rudnev, AV, Stingeder, G & Keppler, B 2005, 'Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins - Significance for the patient', International Journal of Clinical Pharmacology and Therapeutics, vol. 43, no. 12, pp. 583-585. <http://www.scopus.com/scopus/inward/record.url?eid=2-s2.0-29444434345&partnerID@&rel=R5.6.0>

TY - JOUR

T1 - Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins - Significance for the patient

AU - Hartinger, Christian

AU - Hann, Stephan

AU - Köllensperger, Gunda

AU - Sulyok, Michael

AU - Größl, Michael

AU - Timerbaev, Andrei

AU - Rudnev, Alexander V.

AU - Stingeder, Gerhard

AU - Keppler, Bernhard

N1 - Coden: ICTHE Affiliations: Institute of Inorganic Chemistry - Bioinorganic, Environmental and Radiochemistry, University of Vienna, Währinger Straße 42, 1090 Vienna, Austria; Department of Chemistry, BOKU, University of Natural Resources and Applied Life Sciences, Vienna, Austria; Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Moscow, Russian Federation Adressen: Keppler, B.K.; Inorganic Chemistry - Bioinorganic, Environmental and Radiochemistry; University of Vienna; Währinger Straße 42 1090 Vienna, Austria; email: [email protected] Source-File: ChemieErgScopus.csv Import aus Scopus: 2-s2.0-29444434345 Importdatum: 09.01.2007 14:08:38 12.02.2008: Datenanforderung 2112 (Import Sachbearbeiter) 09.02.2010: Datenanforderung UNIVIS-DATEN-DAT.RA-2 (Import Sachbearbeiter)

PY - 2005

Y1 - 2005

M3 - Article

SN - 0946-1965

VL - 43

SP - 583

EP - 585

JO - International Journal of Clinical Pharmacology and Therapeutics

JF - International Journal of Clinical Pharmacology and Therapeutics

IS - 12

ER -